Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals
In this HRI surveillance cohort, measuring glucose and HbA1c values did not contribute to PDAC detection. Larger and longer-term studies are needed to determine the final role of glucose and HbA1c monitoring in PDAC surveillance.
Authors
- Jihane Meziani (ORCID: https://orcid.org/0009-0000-4205-6860)
- Marco J. Bruno (ORCID: https://orcid.org/0000-0001-9181-5499)
- Djuna L. Cahen (ORCID: https://orcid.org/0000-0001-6753-4857)
- Brechtje D.M. Koopmann (ORCID: https://orcid.org/0000-0001-5025-5050)
- Gwenny M. Fuhler (ORCID: https://orcid.org/0000-0001-9221-4855)
- Frank P. Vleggaar (ORCID: https://orcid.org/0000-0001-8664-5130)
- Paul Fockens (ORCID: https://orcid.org/0000-0002-2382-0672)
- Iris J. M. Levink (ORCID: https://orcid.org/0000-0001-9825-8728)
- Jedidja G.Y. de Jong
Institutions
- Utrecht University (NL)
- Heidelberg University (DE)
- Erasmus MC (NL)
- University Hospital Heidelberg (DE)
- University Medical Center Utrecht (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.14309/ctg.0000000000000777
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85